nodes	percent_of_prediction	percent_of_DWPC	metapath
Imipramine—SLC6A3—Gilles de la Tourette syndrome	0.346	0.431	CbGaD
Imipramine—DRD2—Gilles de la Tourette syndrome	0.258	0.321	CbGaD
Imipramine—HTR2A—Gilles de la Tourette syndrome	0.199	0.248	CbGaD
Imipramine—SLC6A2—autonomic nervous system—Gilles de la Tourette syndrome	0.0043	0.0596	CbGeAlD
Imipramine—HTR7—autonomic nervous system—Gilles de la Tourette syndrome	0.00414	0.0574	CbGeAlD
Imipramine—HTR2A—autonomic nervous system—Gilles de la Tourette syndrome	0.00258	0.0358	CbGeAlD
Imipramine—KCND2—midbrain—Gilles de la Tourette syndrome	0.00185	0.0256	CbGeAlD
Imipramine—KCND3—midbrain—Gilles de la Tourette syndrome	0.00161	0.0223	CbGeAlD
Imipramine—KCND2—nervous system—Gilles de la Tourette syndrome	0.00152	0.021	CbGeAlD
Imipramine—KCND2—central nervous system—Gilles de la Tourette syndrome	0.00146	0.0202	CbGeAlD
Imipramine—KCND3—nervous system—Gilles de la Tourette syndrome	0.00132	0.0183	CbGeAlD
Imipramine—KCND3—central nervous system—Gilles de la Tourette syndrome	0.00127	0.0176	CbGeAlD
Imipramine—CHRM4—nervous system—Gilles de la Tourette syndrome	0.00126	0.0175	CbGeAlD
Imipramine—CHRM4—central nervous system—Gilles de la Tourette syndrome	0.00121	0.0168	CbGeAlD
Imipramine—KCND2—brain—Gilles de la Tourette syndrome	0.00116	0.0161	CbGeAlD
Imipramine—HTR6—nervous system—Gilles de la Tourette syndrome	0.00113	0.0156	CbGeAlD
Imipramine—HTR6—central nervous system—Gilles de la Tourette syndrome	0.00109	0.015	CbGeAlD
Imipramine—KCND3—brain—Gilles de la Tourette syndrome	0.00101	0.014	CbGeAlD
Imipramine—CHRM5—nervous system—Gilles de la Tourette syndrome	0.000985	0.0136	CbGeAlD
Imipramine—CHRM4—brain—Gilles de la Tourette syndrome	0.000963	0.0133	CbGeAlD
Imipramine—CHRM5—central nervous system—Gilles de la Tourette syndrome	0.000948	0.0131	CbGeAlD
Imipramine—ADRA1B—nervous system—Gilles de la Tourette syndrome	0.0009	0.0125	CbGeAlD
Imipramine—ADRA1D—nervous system—Gilles de la Tourette syndrome	0.00088	0.0122	CbGeAlD
Imipramine—ADRA1B—central nervous system—Gilles de la Tourette syndrome	0.000867	0.012	CbGeAlD
Imipramine—HTR6—brain—Gilles de la Tourette syndrome	0.000862	0.0119	CbGeAlD
Imipramine—ADRA1D—central nervous system—Gilles de la Tourette syndrome	0.000848	0.0117	CbGeAlD
Imipramine—SLC6A3—midbrain—Gilles de la Tourette syndrome	0.00082	0.0114	CbGeAlD
Imipramine—HTR2C—midbrain—Gilles de la Tourette syndrome	0.000793	0.011	CbGeAlD
Imipramine—CHRM5—brain—Gilles de la Tourette syndrome	0.000753	0.0104	CbGeAlD
Imipramine—SLC6A4—midbrain—Gilles de la Tourette syndrome	0.000752	0.0104	CbGeAlD
Imipramine—ORM1—nervous system—Gilles de la Tourette syndrome	0.000725	0.01	CbGeAlD
Imipramine—ORM1—central nervous system—Gilles de la Tourette syndrome	0.000698	0.00967	CbGeAlD
Imipramine—ADRA1B—brain—Gilles de la Tourette syndrome	0.000688	0.00953	CbGeAlD
Imipramine—CHRM2—nervous system—Gilles de la Tourette syndrome	0.000676	0.00937	CbGeAlD
Imipramine—SLC6A3—nervous system—Gilles de la Tourette syndrome	0.000674	0.00934	CbGeAlD
Imipramine—ADRA1D—brain—Gilles de la Tourette syndrome	0.000673	0.00932	CbGeAlD
Imipramine—HTR1A—midbrain—Gilles de la Tourette syndrome	0.000667	0.00925	CbGeAlD
Imipramine—SLC22A1—nervous system—Gilles de la Tourette syndrome	0.000664	0.0092	CbGeAlD
Imipramine—HTR2C—nervous system—Gilles de la Tourette syndrome	0.000652	0.00903	CbGeAlD
Imipramine—CHRM2—central nervous system—Gilles de la Tourette syndrome	0.000651	0.00902	CbGeAlD
Imipramine—SLC6A3—central nervous system—Gilles de la Tourette syndrome	0.000649	0.00899	CbGeAlD
Imipramine—SLC22A1—central nervous system—Gilles de la Tourette syndrome	0.000639	0.00886	CbGeAlD
Imipramine—HTR7—midbrain—Gilles de la Tourette syndrome	0.000638	0.00884	CbGeAlD
Imipramine—SLC22A3—nervous system—Gilles de la Tourette syndrome	0.000635	0.0088	CbGeAlD
Imipramine—HTR2C—central nervous system—Gilles de la Tourette syndrome	0.000627	0.00869	CbGeAlD
Imipramine—SLC6A4—nervous system—Gilles de la Tourette syndrome	0.000618	0.00856	CbGeAlD
Imipramine—CHRM1—nervous system—Gilles de la Tourette syndrome	0.000615	0.00853	CbGeAlD
Imipramine—SLC22A3—central nervous system—Gilles de la Tourette syndrome	0.000611	0.00847	CbGeAlD
Imipramine—DRD2—midbrain—Gilles de la Tourette syndrome	0.000603	0.00835	CbGeAlD
Imipramine—SLC6A4—central nervous system—Gilles de la Tourette syndrome	0.000595	0.00824	CbGeAlD
Imipramine—KCNH2—midbrain—Gilles de la Tourette syndrome	0.000594	0.00823	CbGeAlD
Imipramine—CHRM1—central nervous system—Gilles de la Tourette syndrome	0.000593	0.00821	CbGeAlD
Imipramine—CHRM3—nervous system—Gilles de la Tourette syndrome	0.000551	0.00763	CbGeAlD
Imipramine—HTR1A—nervous system—Gilles de la Tourette syndrome	0.000549	0.0076	CbGeAlD
Imipramine—SLC6A2—nervous system—Gilles de la Tourette syndrome	0.000544	0.00754	CbGeAlD
Imipramine—SLC22A4—brain—Gilles de la Tourette syndrome	0.000533	0.00739	CbGeAlD
Imipramine—CHRM3—central nervous system—Gilles de la Tourette syndrome	0.00053	0.00735	CbGeAlD
Imipramine—HTR1A—central nervous system—Gilles de la Tourette syndrome	0.000528	0.00732	CbGeAlD
Imipramine—HTR7—nervous system—Gilles de la Tourette syndrome	0.000524	0.00726	CbGeAlD
Imipramine—SLC6A2—central nervous system—Gilles de la Tourette syndrome	0.000524	0.00726	CbGeAlD
Imipramine—CHRM2—brain—Gilles de la Tourette syndrome	0.000517	0.00716	CbGeAlD
Imipramine—SLC6A3—brain—Gilles de la Tourette syndrome	0.000515	0.00714	CbGeAlD
Imipramine—SLC22A1—brain—Gilles de la Tourette syndrome	0.000508	0.00703	CbGeAlD
Imipramine—ADRA1A—nervous system—Gilles de la Tourette syndrome	0.000506	0.00701	CbGeAlD
Imipramine—HTR7—central nervous system—Gilles de la Tourette syndrome	0.000505	0.00699	CbGeAlD
Imipramine—HTR2C—brain—Gilles de la Tourette syndrome	0.000498	0.0069	CbGeAlD
Imipramine—DRD2—nervous system—Gilles de la Tourette syndrome	0.000496	0.00687	CbGeAlD
Imipramine—KCNH2—nervous system—Gilles de la Tourette syndrome	0.000488	0.00677	CbGeAlD
Imipramine—ADRA1A—central nervous system—Gilles de la Tourette syndrome	0.000487	0.00675	CbGeAlD
Imipramine—SLC22A3—brain—Gilles de la Tourette syndrome	0.000485	0.00672	CbGeAlD
Imipramine—DRD2—central nervous system—Gilles de la Tourette syndrome	0.000477	0.00661	CbGeAlD
Imipramine—SLC6A4—brain—Gilles de la Tourette syndrome	0.000472	0.00654	CbGeAlD
Imipramine—CHRM1—brain—Gilles de la Tourette syndrome	0.00047	0.00652	CbGeAlD
Imipramine—KCNH2—central nervous system—Gilles de la Tourette syndrome	0.00047	0.00652	CbGeAlD
Imipramine—CHRM3—brain—Gilles de la Tourette syndrome	0.000421	0.00583	CbGeAlD
Imipramine—HTR1A—brain—Gilles de la Tourette syndrome	0.000419	0.00581	CbGeAlD
Imipramine—SLC6A2—brain—Gilles de la Tourette syndrome	0.000416	0.00576	CbGeAlD
Imipramine—CYP2B6—nervous system—Gilles de la Tourette syndrome	0.000401	0.00555	CbGeAlD
Imipramine—HTR7—brain—Gilles de la Tourette syndrome	0.000401	0.00555	CbGeAlD
Imipramine—HTR2A—midbrain—Gilles de la Tourette syndrome	0.000398	0.00551	CbGeAlD
Imipramine—HRH1—nervous system—Gilles de la Tourette syndrome	0.000391	0.00542	CbGeAlD
Imipramine—ADRA1A—brain—Gilles de la Tourette syndrome	0.000387	0.00536	CbGeAlD
Imipramine—CYP2B6—central nervous system—Gilles de la Tourette syndrome	0.000386	0.00535	CbGeAlD
Imipramine—DRD2—brain—Gilles de la Tourette syndrome	0.000379	0.00525	CbGeAlD
Imipramine—HRH1—central nervous system—Gilles de la Tourette syndrome	0.000377	0.00522	CbGeAlD
Imipramine—CYP2E1—nervous system—Gilles de la Tourette syndrome	0.000376	0.00521	CbGeAlD
Imipramine—KCNH2—brain—Gilles de la Tourette syndrome	0.000373	0.00517	CbGeAlD
Imipramine—CYP2E1—central nervous system—Gilles de la Tourette syndrome	0.000362	0.00502	CbGeAlD
Imipramine—Maprotiline—SLC6A3—Gilles de la Tourette syndrome	0.000353	0.0442	CrCbGaD
Imipramine—HTR2A—nervous system—Gilles de la Tourette syndrome	0.000327	0.00453	CbGeAlD
Imipramine—HTR2A—central nervous system—Gilles de la Tourette syndrome	0.000315	0.00436	CbGeAlD
Imipramine—CYP2B6—brain—Gilles de la Tourette syndrome	0.000306	0.00425	CbGeAlD
Imipramine—CYP3A4—nervous system—Gilles de la Tourette syndrome	0.000303	0.00419	CbGeAlD
Imipramine—HRH1—brain—Gilles de la Tourette syndrome	0.000299	0.00415	CbGeAlD
Imipramine—CYP2D6—nervous system—Gilles de la Tourette syndrome	0.000298	0.00413	CbGeAlD
Imipramine—CYP3A4—central nervous system—Gilles de la Tourette syndrome	0.000291	0.00404	CbGeAlD
Imipramine—CYP2E1—brain—Gilles de la Tourette syndrome	0.000288	0.00398	CbGeAlD
Imipramine—CYP2D6—central nervous system—Gilles de la Tourette syndrome	0.000287	0.00397	CbGeAlD
Imipramine—Prochlorperazine—DRD3—Gilles de la Tourette syndrome	0.000282	0.0353	CrCbGaD
Imipramine—Maprotiline—DRD2—Gilles de la Tourette syndrome	0.000263	0.0329	CrCbGaD
Imipramine—ABCB1—midbrain—Gilles de la Tourette syndrome	0.000261	0.00361	CbGeAlD
Imipramine—Cyamemazine—HTR2A—Gilles de la Tourette syndrome	0.000255	0.032	CrCbGaD
Imipramine—Mianserin—DRD3—Gilles de la Tourette syndrome	0.000255	0.032	CrCbGaD
Imipramine—HTR2A—brain—Gilles de la Tourette syndrome	0.00025	0.00346	CbGeAlD
Imipramine—Methotrimeprazine—DRD4—Gilles de la Tourette syndrome	0.000243	0.0305	CrCbGaD
Imipramine—Cyclobenzaprine—HTR2A—Gilles de la Tourette syndrome	0.000237	0.0298	CrCbGaD
Imipramine—Mianserin—SLC6A3—Gilles de la Tourette syndrome	0.000237	0.0297	CrCbGaD
Imipramine—Epinastine—HTR2A—Gilles de la Tourette syndrome	0.000236	0.0295	CrCbGaD
Imipramine—Triflupromazine—DRD2—Gilles de la Tourette syndrome	0.000229	0.0288	CrCbGaD
Imipramine—CYP2D6—brain—Gilles de la Tourette syndrome	0.000228	0.00315	CbGeAlD
Imipramine—ABCB1—nervous system—Gilles de la Tourette syndrome	0.000214	0.00297	CbGeAlD
Imipramine—Acepromazine—DRD2—Gilles de la Tourette syndrome	0.000212	0.0266	CrCbGaD
Imipramine—Promazine—DRD4—Gilles de la Tourette syndrome	0.000211	0.0264	CrCbGaD
Imipramine—Methotrimeprazine—DRD3—Gilles de la Tourette syndrome	0.00021	0.0263	CrCbGaD
Imipramine—Thioproperazine—DRD2—Gilles de la Tourette syndrome	0.000208	0.026	CrCbGaD
Imipramine—ABCB1—central nervous system—Gilles de la Tourette syndrome	0.000206	0.00286	CbGeAlD
Imipramine—Pipotiazine—DRD2—Gilles de la Tourette syndrome	0.000204	0.0256	CrCbGaD
Imipramine—Maprotiline—HTR2A—Gilles de la Tourette syndrome	0.000203	0.0254	CrCbGaD
Imipramine—Trimipramine—SLC6A3—Gilles de la Tourette syndrome	0.0002	0.025	CrCbGaD
Imipramine—Prochlorperazine—DRD2—Gilles de la Tourette syndrome	0.000195	0.0245	CrCbGaD
Imipramine—Chlorpromazine—DRD4—Gilles de la Tourette syndrome	0.000186	0.0232	CrCbGaD
Imipramine—Mianserin—DRD2—Gilles de la Tourette syndrome	0.000176	0.0221	CrCbGaD
Imipramine—Desipramine—SLC6A3—Gilles de la Tourette syndrome	0.000175	0.0219	CrCbGaD
Imipramine—Acepromazine—HTR2A—Gilles de la Tourette syndrome	0.000164	0.0206	CrCbGaD
Imipramine—ABCB1—brain—Gilles de la Tourette syndrome	0.000164	0.00227	CbGeAlD
Imipramine—Thioproperazine—HTR2A—Gilles de la Tourette syndrome	0.00016	0.0201	CrCbGaD
Imipramine—Chlorpromazine—DRD3—Gilles de la Tourette syndrome	0.00016	0.02	CrCbGaD
Imipramine—Amitriptyline—DRD3—Gilles de la Tourette syndrome	0.000158	0.0198	CrCbGaD
Imipramine—Pipotiazine—HTR2A—Gilles de la Tourette syndrome	0.000158	0.0198	CrCbGaD
Imipramine—Nortriptyline—DRD2—Gilles de la Tourette syndrome	0.000158	0.0198	CrCbGaD
Imipramine—Trimipramine—DRD2—Gilles de la Tourette syndrome	0.000149	0.0186	CrCbGaD
Imipramine—Methotrimeprazine—DRD2—Gilles de la Tourette syndrome	0.000145	0.0182	CrCbGaD
Imipramine—Promethazine—DRD2—Gilles de la Tourette syndrome	0.000143	0.0179	CrCbGaD
Imipramine—Doxepin—DRD2—Gilles de la Tourette syndrome	0.000142	0.0177	CrCbGaD
Imipramine—Mianserin—HTR2A—Gilles de la Tourette syndrome	0.000136	0.0171	CrCbGaD
Imipramine—Desipramine—DRD2—Gilles de la Tourette syndrome	0.00013	0.0163	CrCbGaD
Imipramine—Promazine—DRD2—Gilles de la Tourette syndrome	0.000126	0.0158	CrCbGaD
Imipramine—Clomipramine—HTR2A—Gilles de la Tourette syndrome	0.000125	0.0156	CrCbGaD
Imipramine—Nortriptyline—HTR2A—Gilles de la Tourette syndrome	0.000122	0.0153	CrCbGaD
Imipramine—Trimipramine—HTR2A—Gilles de la Tourette syndrome	0.000115	0.0144	CrCbGaD
Imipramine—Methotrimeprazine—HTR2A—Gilles de la Tourette syndrome	0.000112	0.0141	CrCbGaD
Imipramine—Chlorpromazine—DRD2—Gilles de la Tourette syndrome	0.000111	0.0139	CrCbGaD
Imipramine—Promethazine—HTR2A—Gilles de la Tourette syndrome	0.00011	0.0138	CrCbGaD
Imipramine—Amitriptyline—DRD2—Gilles de la Tourette syndrome	0.000109	0.0137	CrCbGaD
Imipramine—Doxepin—HTR2A—Gilles de la Tourette syndrome	0.000109	0.0137	CrCbGaD
Imipramine—Desipramine—HTR2A—Gilles de la Tourette syndrome	0.0001	0.0126	CrCbGaD
Imipramine—Promazine—HTR2A—Gilles de la Tourette syndrome	9.72e-05	0.0122	CrCbGaD
Imipramine—Chlorpromazine—HTR2A—Gilles de la Tourette syndrome	8.55e-05	0.0107	CrCbGaD
Imipramine—Amitriptyline—HTR2A—Gilles de la Tourette syndrome	8.46e-05	0.0106	CrCbGaD
Imipramine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	6.8e-05	0.000581	CbGpPWpGaD
Imipramine—HTR2C—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	6.8e-05	0.000581	CbGpPWpGaD
Imipramine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	6.8e-05	0.000581	CbGpPWpGaD
Imipramine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	6.78e-05	0.000579	CbGpPWpGaD
Imipramine—CYP3A7—Metabolism—HDC—Gilles de la Tourette syndrome	6.73e-05	0.000575	CbGpPWpGaD
Imipramine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	6.72e-05	0.000574	CbGpPWpGaD
Imipramine—SLC22A2—Metabolism—HDC—Gilles de la Tourette syndrome	6.72e-05	0.000574	CbGpPWpGaD
Imipramine—ADRA1B—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	6.71e-05	0.000573	CbGpPWpGaD
Imipramine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	6.69e-05	0.000572	CbGpPWpGaD
Imipramine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	6.51e-05	0.000556	CbGpPWpGaD
Imipramine—ADRA1B—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	6.51e-05	0.000556	CbGpPWpGaD
Imipramine—HTR1A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	6.37e-05	0.000544	CbGpPWpGaD
Imipramine—HTR2C—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	6.34e-05	0.000542	CbGpPWpGaD
Imipramine—SLC22A1—Metabolism—HDC—Gilles de la Tourette syndrome	6.26e-05	0.000535	CbGpPWpGaD
Imipramine—SLC6A2—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	6.19e-05	0.000529	CbGpPWpGaD
Imipramine—DRD2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	6.18e-05	0.000528	CbGpPWpGaD
Imipramine—HTR2A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	6.09e-05	0.00052	CbGpPWpGaD
Imipramine—HRH1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	6.07e-05	0.000519	CbGpPWpGaD
Imipramine—ADRA1B—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	6.07e-05	0.000518	CbGpPWpGaD
Imipramine—CHRM1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	6.05e-05	0.000517	CbGpPWpGaD
Imipramine—CHRM3—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	6.03e-05	0.000516	CbGpPWpGaD
Imipramine—HTR6—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	6.03e-05	0.000515	CbGpPWpGaD
Imipramine—HTR7—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	6.02e-05	0.000514	CbGpPWpGaD
Imipramine—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	6e-05	0.000513	CbGpPWpGaD
Imipramine—DRD2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	6e-05	0.000513	CbGpPWpGaD
Imipramine—CHRM2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	5.98e-05	0.000511	CbGpPWpGaD
Imipramine—ADRA1A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	5.96e-05	0.000509	CbGpPWpGaD
Imipramine—HTR2A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	5.91e-05	0.000505	CbGpPWpGaD
Imipramine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	5.9e-05	0.000504	CbGpPWpGaD
Imipramine—HRH1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	5.9e-05	0.000504	CbGpPWpGaD
Imipramine—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	5.88e-05	0.000502	CbGpPWpGaD
Imipramine—CHRM1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	5.88e-05	0.000502	CbGpPWpGaD
Imipramine—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	5.86e-05	0.000501	CbGpPWpGaD
Imipramine—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	5.86e-05	0.000501	CbGpPWpGaD
Imipramine—CHRM3—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	5.86e-05	0.0005	CbGpPWpGaD
Imipramine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	5.83e-05	0.000498	CbGpPWpGaD
Imipramine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	5.8e-05	0.000496	CbGpPWpGaD
Imipramine—CHRM2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	5.8e-05	0.000496	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—HDC—Gilles de la Tourette syndrome	5.79e-05	0.000494	CbGpPWpGaD
Imipramine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	5.79e-05	0.000494	CbGpPWpGaD
Imipramine—ADRA1A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	5.78e-05	0.000494	CbGpPWpGaD
Imipramine—CHRM4—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	5.69e-05	0.000486	CbGpPWpGaD
Imipramine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	5.58e-05	0.000477	CbGpPWpGaD
Imipramine—HTR2A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	5.5e-05	0.00047	CbGpPWpGaD
Imipramine—HRH1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	5.49e-05	0.000469	CbGpPWpGaD
Imipramine—CHRM1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	5.47e-05	0.000468	CbGpPWpGaD
Imipramine—CHRM3—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	5.46e-05	0.000466	CbGpPWpGaD
Imipramine—CHRM5—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	5.45e-05	0.000465	CbGpPWpGaD
Imipramine—CHRM2—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	5.4e-05	0.000462	CbGpPWpGaD
Imipramine—ADRA1A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	5.39e-05	0.00046	CbGpPWpGaD
Imipramine—HTR6—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	5.38e-05	0.00046	CbGpPWpGaD
Imipramine—HTR7—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	5.37e-05	0.000459	CbGpPWpGaD
Imipramine—HTR6—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	5.22e-05	0.000446	CbGpPWpGaD
Imipramine—HTR7—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	5.22e-05	0.000446	CbGpPWpGaD
Imipramine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	5.14e-05	0.00044	CbGpPWpGaD
Imipramine—ADRA1D—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	5.12e-05	0.000437	CbGpPWpGaD
Imipramine—CHRM4—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	5.07e-05	0.000433	CbGpPWpGaD
Imipramine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	5.05e-05	0.000432	CbGpPWpGaD
Imipramine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	5.03e-05	0.00043	CbGpPWpGaD
Imipramine—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	5.02e-05	0.000429	CbGpPWpGaD
Imipramine—SLC22A2—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	4.99e-05	0.000427	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—HDC—Gilles de la Tourette syndrome	4.98e-05	0.000425	CbGpPWpGaD
Imipramine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	4.97e-05	0.000425	CbGpPWpGaD
Imipramine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	4.96e-05	0.000423	CbGpPWpGaD
Imipramine—CHRM4—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.93e-05	0.000421	CbGpPWpGaD
Imipramine—HTR6—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.88e-05	0.000417	CbGpPWpGaD
Imipramine—HTR7—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.88e-05	0.000417	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—HDC—Gilles de la Tourette syndrome	4.87e-05	0.000417	CbGpPWpGaD
Imipramine—HTR6—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.86e-05	0.000416	CbGpPWpGaD
Imipramine—CHRM5—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.86e-05	0.000415	CbGpPWpGaD
Imipramine—HTR7—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.86e-05	0.000415	CbGpPWpGaD
Imipramine—HTR6—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.74e-05	0.000405	CbGpPWpGaD
Imipramine—HTR7—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.74e-05	0.000405	CbGpPWpGaD
Imipramine—CHRM5—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.72e-05	0.000403	CbGpPWpGaD
Imipramine—SLC22A1—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	4.65e-05	0.000398	CbGpPWpGaD
Imipramine—CHRM4—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.61e-05	0.000394	CbGpPWpGaD
Imipramine—CHRM4—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.59e-05	0.000392	CbGpPWpGaD
Imipramine—ADRA1D—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.57e-05	0.00039	CbGpPWpGaD
Imipramine—CHRM4—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.47e-05	0.000382	CbGpPWpGaD
Imipramine—HTR1A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	4.46e-05	0.000381	CbGpPWpGaD
Imipramine—HTR2C—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	4.44e-05	0.000379	CbGpPWpGaD
Imipramine—ADRA1D—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.43e-05	0.000379	CbGpPWpGaD
Imipramine—HTR6—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	4.42e-05	0.000377	CbGpPWpGaD
Imipramine—HTR7—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	4.41e-05	0.000377	CbGpPWpGaD
Imipramine—CHRM5—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.41e-05	0.000377	CbGpPWpGaD
Imipramine—CHRM5—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.39e-05	0.000375	CbGpPWpGaD
Imipramine—CHRM5—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.28e-05	0.000366	CbGpPWpGaD
Imipramine—ADRA1B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	4.25e-05	0.000363	CbGpPWpGaD
Imipramine—CHRM4—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	4.17e-05	0.000356	CbGpPWpGaD
Imipramine—ADRA1D—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.15e-05	0.000354	CbGpPWpGaD
Imipramine—ADRA1D—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.13e-05	0.000353	CbGpPWpGaD
Imipramine—ADRA1D—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.03e-05	0.000344	CbGpPWpGaD
Imipramine—CHRM5—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.99e-05	0.000341	CbGpPWpGaD
Imipramine—HTR1A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.98e-05	0.00034	CbGpPWpGaD
Imipramine—HTR2C—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.96e-05	0.000338	CbGpPWpGaD
Imipramine—DRD2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	3.92e-05	0.000335	CbGpPWpGaD
Imipramine—HTR1A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.86e-05	0.00033	CbGpPWpGaD
Imipramine—HRH1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	3.85e-05	0.000329	CbGpPWpGaD
Imipramine—HTR2C—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.84e-05	0.000329	CbGpPWpGaD
Imipramine—CHRM1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	3.83e-05	0.000328	CbGpPWpGaD
Imipramine—CHRM3—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	3.82e-05	0.000327	CbGpPWpGaD
Imipramine—ADRA1B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.79e-05	0.000324	CbGpPWpGaD
Imipramine—CHRM2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	3.78e-05	0.000323	CbGpPWpGaD
Imipramine—ADRA1A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	3.77e-05	0.000322	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—HDC—Gilles de la Tourette syndrome	3.76e-05	0.000321	CbGpPWpGaD
Imipramine—ADRA1D—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.75e-05	0.000321	CbGpPWpGaD
Imipramine—ADRA1B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.68e-05	0.000314	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—HDC—Gilles de la Tourette syndrome	3.67e-05	0.000314	CbGpPWpGaD
Imipramine—HTR1A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.62e-05	0.000309	CbGpPWpGaD
Imipramine—HTR1A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.6e-05	0.000308	CbGpPWpGaD
Imipramine—HTR2C—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.6e-05	0.000307	CbGpPWpGaD
Imipramine—HTR2C—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.58e-05	0.000306	CbGpPWpGaD
Imipramine—HTR1A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.51e-05	0.0003	CbGpPWpGaD
Imipramine—DRD2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.5e-05	0.000299	CbGpPWpGaD
Imipramine—HTR2C—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.49e-05	0.000298	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—HDC—Gilles de la Tourette syndrome	3.46e-05	0.000296	CbGpPWpGaD
Imipramine—ADRA1B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.44e-05	0.000294	CbGpPWpGaD
Imipramine—HTR2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.44e-05	0.000294	CbGpPWpGaD
Imipramine—HRH1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.43e-05	0.000293	CbGpPWpGaD
Imipramine—ADRA1B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.43e-05	0.000293	CbGpPWpGaD
Imipramine—CHRM1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.42e-05	0.000292	CbGpPWpGaD
Imipramine—CHRM3—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.41e-05	0.000291	CbGpPWpGaD
Imipramine—HTR6—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.41e-05	0.000291	CbGpPWpGaD
Imipramine—HTR7—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.4e-05	0.000291	CbGpPWpGaD
Imipramine—DRD2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.39e-05	0.00029	CbGpPWpGaD
Imipramine—CHRM2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.38e-05	0.000289	CbGpPWpGaD
Imipramine—ADRA1A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.37e-05	0.000288	CbGpPWpGaD
Imipramine—ADRA1B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.34e-05	0.000286	CbGpPWpGaD
Imipramine—HTR2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.34e-05	0.000285	CbGpPWpGaD
Imipramine—HRH1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.33e-05	0.000285	CbGpPWpGaD
Imipramine—CHRM1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.32e-05	0.000284	CbGpPWpGaD
Imipramine—CHRM3—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.31e-05	0.000283	CbGpPWpGaD
Imipramine—CHRM2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.28e-05	0.00028	CbGpPWpGaD
Imipramine—HTR1A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.27e-05	0.000279	CbGpPWpGaD
Imipramine—ADRA1A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.27e-05	0.000279	CbGpPWpGaD
Imipramine—HTR2C—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.25e-05	0.000278	CbGpPWpGaD
Imipramine—CHRM4—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.21e-05	0.000275	CbGpPWpGaD
Imipramine—DRD2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.17e-05	0.000271	CbGpPWpGaD
Imipramine—HTR2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.12e-05	0.000267	CbGpPWpGaD
Imipramine—HRH1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.12e-05	0.000266	CbGpPWpGaD
Imipramine—ADRA1B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.11e-05	0.000266	CbGpPWpGaD
Imipramine—HTR2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.11e-05	0.000266	CbGpPWpGaD
Imipramine—CHRM1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.11e-05	0.000265	CbGpPWpGaD
Imipramine—HRH1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.1e-05	0.000265	CbGpPWpGaD
Imipramine—CHRM3—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.1e-05	0.000265	CbGpPWpGaD
Imipramine—CHRM1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.09e-05	0.000264	CbGpPWpGaD
Imipramine—HTR6—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.09e-05	0.000264	CbGpPWpGaD
Imipramine—HTR7—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.09e-05	0.000264	CbGpPWpGaD
Imipramine—CHRM3—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.08e-05	0.000263	CbGpPWpGaD
Imipramine—DRD2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.08e-05	0.000263	CbGpPWpGaD
Imipramine—CHRM5—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.08e-05	0.000263	CbGpPWpGaD
Imipramine—CHRM2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.07e-05	0.000262	CbGpPWpGaD
Imipramine—ADRA1A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.06e-05	0.000261	CbGpPWpGaD
Imipramine—CHRM2—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.05e-05	0.000261	CbGpPWpGaD
Imipramine—ADRA1A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.05e-05	0.00026	CbGpPWpGaD
Imipramine—HTR2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.03e-05	0.000259	CbGpPWpGaD
Imipramine—HRH1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.03e-05	0.000258	CbGpPWpGaD
Imipramine—CHRM1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.02e-05	0.000258	CbGpPWpGaD
Imipramine—CHRM3—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.01e-05	0.000257	CbGpPWpGaD
Imipramine—CHRM2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.98e-05	0.000254	CbGpPWpGaD
Imipramine—ADRA1A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.97e-05	0.000254	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—HDC—Gilles de la Tourette syndrome	2.93e-05	0.00025	CbGpPWpGaD
Imipramine—CHRM4—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.92e-05	0.000249	CbGpPWpGaD
Imipramine—ADRA1D—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.89e-05	0.000247	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.88e-05	0.000247	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.88e-05	0.000246	CbGpPWpGaD
Imipramine—HTR2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.82e-05	0.000241	CbGpPWpGaD
Imipramine—HRH1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.82e-05	0.000241	CbGpPWpGaD
Imipramine—CHRM1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.81e-05	0.00024	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.8e-05	0.000239	CbGpPWpGaD
Imipramine—CHRM3—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.8e-05	0.000239	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.8e-05	0.000239	CbGpPWpGaD
Imipramine—CHRM5—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.79e-05	0.000239	CbGpPWpGaD
Imipramine—CHRM2—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.77e-05	0.000237	CbGpPWpGaD
Imipramine—ADRA1A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.77e-05	0.000236	CbGpPWpGaD
Imipramine—ABCB1—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	2.73e-05	0.000233	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.72e-05	0.000233	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.64e-05	0.000226	CbGpPWpGaD
Imipramine—ADRA1D—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.63e-05	0.000224	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.61e-05	0.000223	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.61e-05	0.000223	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.61e-05	0.000223	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.53e-05	0.000216	CbGpPWpGaD
Imipramine—HTR1A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.52e-05	0.000215	CbGpPWpGaD
Imipramine—HTR2C—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.51e-05	0.000214	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.46e-05	0.00021	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.45e-05	0.000209	CbGpPWpGaD
Imipramine—ADRA1B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.4e-05	0.000205	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.38e-05	0.000203	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.36e-05	0.000201	CbGpPWpGaD
Imipramine—HTR1A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.29e-05	0.000196	CbGpPWpGaD
Imipramine—HTR2C—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.28e-05	0.000195	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—HDC—Gilles de la Tourette syndrome	2.26e-05	0.000193	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.22e-05	0.000189	CbGpPWpGaD
Imipramine—DRD2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.21e-05	0.000189	CbGpPWpGaD
Imipramine—ADRA1B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.18e-05	0.000186	CbGpPWpGaD
Imipramine—HRH1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.17e-05	0.000186	CbGpPWpGaD
Imipramine—CHRM1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.17e-05	0.000185	CbGpPWpGaD
Imipramine—CHRM3—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.16e-05	0.000185	CbGpPWpGaD
Imipramine—CHRM2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.14e-05	0.000183	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.14e-05	0.000182	CbGpPWpGaD
Imipramine—ADRA1A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.13e-05	0.000182	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.12e-05	0.000182	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.07e-05	0.000177	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.06e-05	0.000176	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.03e-05	0.000174	CbGpPWpGaD
Imipramine—DRD2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.01e-05	0.000172	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.97e-05	0.000169	CbGpPWpGaD
Imipramine—HRH1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.97e-05	0.000169	CbGpPWpGaD
Imipramine—CHRM1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.97e-05	0.000168	CbGpPWpGaD
Imipramine—CHRM3—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.96e-05	0.000168	CbGpPWpGaD
Imipramine—CHRM2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.94e-05	0.000166	CbGpPWpGaD
Imipramine—ADRA1A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.94e-05	0.000165	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.93e-05	0.000165	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.92e-05	0.000164	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.88e-05	0.00016	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.84e-05	0.000158	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.84e-05	0.000157	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.84e-05	0.000157	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.84e-05	0.000157	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.83e-05	0.000156	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.83e-05	0.000156	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.83e-05	0.000156	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.82e-05	0.000156	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.81e-05	0.000155	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.81e-05	0.000154	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.79e-05	0.000153	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.79e-05	0.000153	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.78e-05	0.000152	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.78e-05	0.000152	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.76e-05	0.00015	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.75e-05	0.00015	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.72e-05	0.000147	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.67e-05	0.000143	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.66e-05	0.000142	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.66e-05	0.000142	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.65e-05	0.000141	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.65e-05	0.000141	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.64e-05	0.00014	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.63e-05	0.00014	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.55e-05	0.000133	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.35e-05	0.000116	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.35e-05	0.000115	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.29e-05	0.00011	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.19e-05	0.000101	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.17e-05	9.96e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.16e-05	9.93e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.16e-05	9.9e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.15e-05	9.8e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.14e-05	9.78e-05	CbGpPWpGaD
